Nine Masts Capital’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-88,000
Closed -$43.6K – 264
2026
Q1
$43.6K Buy
+88,000
New +$2.34M 0.01% 162

Other funds holding PFE

Nine Masts Capital's PFE Position: Q3 2026 in Review

Nine Masts Capital sold out of Pfizer (PFE) in Q3 2026, closing a stake of 68,200 shares — an estimated $1.64M sold.

Nine Masts Capital first reported a position in PFE in Q2 2017 and held it in 4 quarters. The position peaked at $1.64M in Q2 2026. 2,899 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Nine Masts Capital reported no remaining Pfizer position as of Q3 2026 after selling out during the quarter.
  • Nine Masts Capital sold 68,200 Pfizer shares in Q3 2026, an estimated $1.64M.
  • Nine Masts Capital first reported a position in Pfizer in Q2 2017 and held it in 4 quarters.
  • Nine Masts Capital's Pfizer position peaked at $1.64M in Q2 2026.
  • 2,899 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Nine Masts Capital's 13F filing for Q3 2026, filed 9 Nov 2026.